In terms of provisions of Regulation 30 (read with Part A of Schedule III) and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( Listing Regulations ), we wish to inform you that the Board of Directors of the Company, at its meeting held today i.e. 4th May, 2026, inter-alia, has identified and designated Ms. Annapurna Das, President (India Business & Emerging Markets (NCE)), Mr. Om Narayan, Senior Vice President (Biotech Research Centre) and Mr. Sunil Soni, Senior Vice President (Biotechnology) as Senior Management Personnel of the Company.

Wockhardt Limited's Board of Directors has designated three senior executives as Senior Management Personnel (SMP) effective May 4, 2026. The appointees include Ms. Annapurna Das (President - India Business & Emerging Markets) with 26 years of pharma experience including roles at Takeda, Sanofi, and GSK; Mr. Om Narayan (Senior Vice President - Biotech Research Centre) with 30 years in biotech including Piramal, Mylan/Viatris, and Serum Institute; and Mr. Sunil Soni (Senior Vice President - Biotechnology) with 30 years in API and biotech operations at companies like Biological E, Serum Institute, and Lupin. All three appointments are full-time employment positions. This disclosure is made under SEBI LODR Regulation 30, which requires immediate intimation of such designations to stock exchanges.